Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Cardular PP

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 675Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    05/10/2025 Cohance Lifesciences
    India
    		 M/s. Cohance Lifesciences Limited WC-0150N Doxazosin Mesilate Ph. Eur/USP 2025-07-24 2028-07-21 API Unit-l, R.S. No. 50/1, Mukteswarapuram Village,\r\nJaggaiahpet Mandal, NTR District -521457,\r\nAndhra Pradesh, India
    25/11/2025 Anek Prayog Pvt. Ltd.,
    India
    		 M/s. Anek Prayog Pvt. Ltd. WC-0089 Doxazosin Mesilate BP/EP 2025-11-21 2028-08-15 Plot No. 57/2, 119, MIDC IND. Area, Dhatav,Roha -402116, Taluka: Roha,District -Raigad Zone 2, Maharashtra, India